Comparing ICU Admission Rates of Mild/Moderate COVID-19 Patients Treated with Hydroxychloroquine, Favipiravir, and Hydroxychloroquine plus Favipiravir
Güner et al., Journal of Infection and Public Health, doi:10.1016/j.jiph.2020.12.017
https://c19hcq.org/guner.html